205 related articles for article (PubMed ID: 28430645)
1. Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells.
Sun B; Hu C; Yang Z; Zhang X; Zhao L; Xiong J; Ma J; Chen L; Qian H; Luo X; Shi L; Li J; Cheng X; Yin Z
Oncotarget; 2017 May; 8(20):32523-32535. PubMed ID: 28430645
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells.
Lai HC; Yeh CC; Jeng LB; Huang SF; Liao PY; Lei FJ; Cheng WC; Hsu CL; Cai X; Chang C; Ma WL
Oncotarget; 2016 Jul; 7(29):46448-46465. PubMed ID: 27340775
[TBL] [Abstract][Full Text] [Related]
3. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells.
Peng YF; Shi YH; Ding ZB; Ke AW; Gu CY; Hui B; Zhou J; Qiu SJ; Dai Z; Fan J
Autophagy; 2013 Dec; 9(12):2056-68. PubMed ID: 24157892
[TBL] [Abstract][Full Text] [Related]
4. Astrocyte elevated gene 1 (AEG-1) promotes anoikis resistance and metastasis by inducing autophagy in hepatocellular carcinoma.
Zhu HD; Liu L; Deng H; Li ZB; Sheng JQ; He XX; Tian DA; Li PY
J Cell Physiol; 2020 Jun; 235(6):5084-5095. PubMed ID: 31691973
[TBL] [Abstract][Full Text] [Related]
5. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin.
Zhang X; Cheng SL; Bian K; Wang L; Zhang X; Yan B; Jia LT; Zhao J; Gammoh N; Yang AG; Zhang R
Oncotarget; 2015 Feb; 6(4):2277-89. PubMed ID: 25537511
[TBL] [Abstract][Full Text] [Related]
7. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
[TBL] [Abstract][Full Text] [Related]
8. CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis.
Hu X; Zhao Y; Wei L; Zhu B; Song D; Wang J; Yu L; Wu J
Oncogene; 2017 Jul; 36(28):4047-4059. PubMed ID: 28319061
[TBL] [Abstract][Full Text] [Related]
9. Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation.
Feng MX; Ma MZ; Fu Y; Li J; Wang T; Xue F; Zhang JJ; Qin WX; Gu JR; Zhang ZG; Xia Q
Mol Cancer; 2014 Oct; 13():226. PubMed ID: 25273699
[TBL] [Abstract][Full Text] [Related]
10. Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway.
Wang W; Shen XB; Huang DB; Jia W; Liu WB; He YF
Cell Oncol (Dordr); 2019 Dec; 42(6):769-781. PubMed ID: 31256347
[TBL] [Abstract][Full Text] [Related]
11. ZNF32 induces anoikis resistance through maintaining redox homeostasis and activating Src/FAK signaling in hepatocellular carcinoma.
Li K; Zhao G; Ao J; Gong D; Zhang J; Chen Y; Li J; Huang L; Xiang R; Hu J; Lin P; Wei Y
Cancer Lett; 2019 Feb; 442():271-278. PubMed ID: 30439540
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of BNIP3 mediated by ERK/HIF-1α pathway induces autophagy and contributes to anoikis resistance of hepatocellular carcinoma cells.
Sun L; Li T; Wei Q; Zhang Y; Jia X; Wan Z; Han L
Future Oncol; 2014 Jun; 10(8):1387-98. PubMed ID: 25052749
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma.
Fu XT; Shi YH; Zhou J; Peng YF; Liu WR; Shi GM; Gao Q; Wang XY; Song K; Fan J; Ding ZB
Cancer Lett; 2018 Jan; 412():108-117. PubMed ID: 29061507
[TBL] [Abstract][Full Text] [Related]
14. IQGAP1 promotes anoikis resistance and metastasis through Rac1-dependent ROS accumulation and activation of Src/FAK signalling in hepatocellular carcinoma.
Mo CF; Li J; Yang SX; Guo HJ; Liu Y; Luo XY; Wang YT; Li MH; Li JY; Zou Q
Br J Cancer; 2020 Sep; 123(7):1154-1163. PubMed ID: 32632148
[TBL] [Abstract][Full Text] [Related]
15. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.
Gowhari Shabgah A; Ezzatifar F; Aravindhan S; Olegovna Zekiy A; Ahmadi M; Gheibihayat SM; Gholizadeh Navashenaq J
IUBMB Life; 2021 Apr; 73(4):659-669. PubMed ID: 33625758
[TBL] [Abstract][Full Text] [Related]
16. HRC promotes anoikis resistance and metastasis by suppressing endoplasmic reticulum stress in hepatocellular carcinoma.
Xia S; Wu J; Zhou W; Zhang M; Zhao K; Tian D; Liu J; Liao J
Int J Med Sci; 2021; 18(14):3112-3124. PubMed ID: 34400882
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells are correlated with disease progression and treatment response in an orthotopic hepatocellular carcinoma model.
Yan J; Fan Z; Wu X; Xu M; Jiang J; Tan C; Wu W; Wei X; Zhou J
Cytometry A; 2015 Nov; 87(11):1020-8. PubMed ID: 26355643
[TBL] [Abstract][Full Text] [Related]
18. Tiam1 is associated with hepatocellular carcinoma metastasis.
Huang J; Ye X; Guan J; Chen B; Li Q; Zheng X; Liu L; Wang S; Ding Y; Ding Y; Chen L
Int J Cancer; 2013 Jan; 132(1):90-100. PubMed ID: 22573407
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
Kelley RK; Magbanua MJ; Butler TM; Collisson EA; Hwang J; Sidiropoulos N; Evason K; McWhirter RM; Hameed B; Wayne EM; Yao FY; Venook AP; Park JW
BMC Cancer; 2015 Mar; 15():206. PubMed ID: 25884197
[TBL] [Abstract][Full Text] [Related]
20. An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients.
Liu YK; Hu BS; Li ZL; He X; Li Y; Lu LG
Hepatol Int; 2016 Jul; 10(4):640-6. PubMed ID: 27115761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
